News
· 21hCEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
20hon MSN
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
20hon MSN
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback